LanZhou Foci Pharmaceutical Co.,Ltd.

符号: 002644.SZ

SHZ

7.78

CNY

今天的市场价格

68.3675
市盈率
-2.3694
PEG比率
3.97B
MRK市值
0.01%
DIV收益率

LanZhou Foci Pharmaceutical Co.,Ltd. (002644-SZ) 财务报表

Q: 什么是 LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) 总资产是多少？

LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ). 的默认数据。公司收入显示 479.567 M 的平均值，即 0.118 % 增长率。整个期间的平均毛利润为 143.126 M，即 0.116 %. 平均毛利率为 0.314 %. 公司去年的净收入增长率为 -0.382 %，等于 0.109 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 LanZhou Foci Pharmaceutical Co.,Ltd. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 -0.023. 在流动资产领域，002644.SZ 的报告货币为1238.869. 这些资产中的很大一部分，即 406.041 是现金和短期投资。与去年的数据相比，该部分的变化率为0.019%. 公司的长期投资虽然不是其重点，但以报告货币计算的79.875（如果有的话）为79.875。这表明与上一报告期相比，19.813% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 1.346. 这一数字表明，0.812% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 1745.371. 这方面的年同比变化率为 0.017%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为441.812，存货估值为 369.72，商誉估值为 9.01（如有. 无形资产总额（如果有）按 79.55 估值.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008
balance-sheet.row.cash-and-short-term-investments	1413.19	406	398.5	374.9	452	434.7	465.5	70.2	418.6	499	275.6	161.8	190	325.5	67.8	18.7	9.3	6.6
balance-sheet.row.short-term-investments	-70.42	-15.8	2	-10.4	32.1	-18.2	-5.1	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	2046.86	441.8	526.5	390.8	335.1	312	200.1	157	110.8	126.6	157.4	237.1	131.9	100.3	77.2	116.3	77.5	66.8
balance-sheet.row.inventory	1526.12	369.7	350.4	258.8	258.3	286.8	241.3	196.6	191.2	159.3	138	124.7	150.2	140.1	85.6	79.9	76	48.1
balance-sheet.row.other-current-assets	74.04	21.3	15.7	10	8.7	2.9	19.6	673.9	699.8	226.2	-2	-3	-4.4	-6.1	-3.8	-7.8	-1.3	-6.9
balance-sheet.row.total-current-assets	5060.22	1238.9	1291.1	1034.6	1054.1	1036.3	926.5	1097.7	1420.4	1011	569.1	520.8	467.7	559.7	226.8	207.1	161.5	114.6
balance-sheet.row.property-plant-equipment-net	4211.94	1061.8	1066.8	1091.6	1110.4	1134.5	1407.3	1100	471.2	220.6	319.8	294.1	267.8	183.2	151.7	137	136	138.5
balance-sheet.row.goodwill	26.96	9	4.5	4.5	4.5	4.5	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	320.66	79.6	76.8	72	74	75.8	124.8	127.6	118.7	120.3	147.9	84.5	85.4	84.7	71.9	74.2	101.3	104.2
balance-sheet.row.goodwill-and-intangible-assets	347.63	88.6	81.3	76.4	78.5	80.3	124.8	127.6	118.7	120.3	147.9	84.5	85.4	84.7	71.9	74.2	101.3	104.2
balance-sheet.row.long-term-investments	335.99	79.9	66.7	82.1	41.5	95.5	47.6	5.7	6.1	39.2	159.7	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	205.41	53.6	52.4	51.1	51.3	53.6	5	5.4	4.9	4.2	2.9	2.5	2	1.6	1.5	0.7	0.5	1.5
balance-sheet.row.other-non-current-assets	54.24	5.3	28.4	16.2	51.3	0.4	12.9	13.5	15.4	-32.8	-152.8	1.2	0	0	4.3	3	1.3	1.3
balance-sheet.row.total-non-current-assets	5155.21	1289.2	1295.5	1317.5	1333	1364.3	1597.5	1252.2	616.3	351.4	477.5	382.3	355.2	269.5	229.4	214.9	239.1	245.4
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	10215.43	2528.1	2586.6	2352.1	2387.2	2400.7	2524	2349.8	2036.7	1362.4	1046.6	903.1	822.9	829.2	456.2	422	400.5	359.9
balance-sheet.row.account-payables	1338.65	310.4	311	214.3	300.2	372.5	451.7	323.7	104.1	52.7	63.4	15.2	43.9	58.3	29.5	38.6	42.6	26.2
balance-sheet.row.short-term-debt	98.74	24.7	13.8	14.7	34	14.5	17.3	0	0	0	26	124	76	76	46	46	59	34
balance-sheet.row.tax-payables	130.95	35.1	69.4	47.6	49.2	48.5	7.7	13.3	2.6	2.5	2.4	3.6	4.1	12.2	10.3	3.5	1.4	2.4
balance-sheet.row.long-term-debt-total	14.55	1.3	0.5	0.8	66.6	80	387	109.4	108.1	0	0	0	2	2	2	2	2	15
Deferred Revenue Non Current	1056.95	261	278.2	295	310.2	328.4	189.4	21.8	24.4	26.2	6.8	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	10.03	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	19.4	5.8	110.9	4.5	1.1	13.4	30.3	47.2	32.1	34.8	11.2	6.1	4.3	3.7	3.8	11.6	1.7	4.8
balance-sheet.row.total-non-current-liabilities	1174.53	292	322.1	349.8	377.6	409.3	576.4	619.8	610	41.2	197.4	38.9	14.7	13.6	13.4	11	10.6	25.2
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	3.23	1.3	0.5	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	3126.08	759.7	852.6	724.6	800.1	893.8	1083.6	990.7	746.1	128.8	311.4	199.7	147.4	181.1	129.7	169.1	183.7	164.7
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	2042.63	510.7	510.7	510.7	510.7	510.7	510.7	510.7	510.7	510.7	177.7	88.9	88.9	80.8	60.6	60.6	60.6	60.6
balance-sheet.row.retained-earnings	3119.21	776.2	746.9	654.5	631.9	565.1	507.6	448.5	387.8	337.5	302.3	274.1	249.4	233.1	204.2	158.1	125.5	106.1
balance-sheet.row.accumulated-other-comprehensive-income-loss	1237.35	158.4	152	143.6	133.8	123.9	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	605.87	300.1	305.8	305.8	305.8	305.2	422.2	400	392.1	385.5	255.2	340.4	337.3	334.3	61.7	34.3	30.7	28.5
balance-sheet.row.total-stockholders-equity	7005.06	1745.4	1715.4	1614.6	1582.1	1504.9	1440.4	1359.1	1290.6	1233.7	735.2	703.4	675.5	648.1	326.5	253	216.8	195.2
balance-sheet.row.total-liabilities-and-stockholders-equity	10215.43	2528.1	2586.6	2352.1	2387.2	2400.7	2524	2349.8	2036.7	1362.4	1046.6	903.1	822.9	829.2	456.2	422	400.5	359.9
balance-sheet.row.minority-interest	84.28	23.1	18.6	12.9	5	2	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	7089.35	1768.4	1734	1627.5	1587.1	1506.9	1440.4	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	10215.43	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	265.57	64.1	68.7	71.7	73.6	77.3	42.5	5.7	6.1	39.2	159.7	0	0	0	0	0	0	0
balance-sheet.row.total-debt	113.29	26	14.4	15.5	34	14.5	17.3	109.4	108.1	0	26	124	78	78	48	48	61	49
balance-sheet.row.net-debt	-1299.9	-380	-382.1	-359.4	-386	-420.1	-448.3	39.2	-310.5	-499	-249.6	-37.8	-112	-247.5	-19.8	29.3	51.7	42.4

现金流量表

在 LanZhou Foci Pharmaceutical Co.,Ltd. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 0.401 的转变。该公司最近通过发行 0 扩大了股本，与上一年相比出现了0.000 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-34155286.360. 与上一年相比， -0.203 发生了变化. 在同一时期，公司记录了 52.49, 1.77 和 -21.45，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-27.94 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 -1.26，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008
cash-flows.row.net-income	58.12	68.1	105.9	93.5	111.7	74.7	74.3	74.1	60.9	42.9	34.7	30.6	30.4	32.1	51.2	36.1	21.6	23.3
cash-flows.row.depreciation-and-amortization	3.63	52.5	49.5	48.6	38.7	53.1	34.2	21	18.5	17.9	14.9	15.2	14.1	6.3	11.3	12.5	13.7	0
cash-flows.row.deferred-income-tax	0	0.2	1	0.2	2.3	-40.7	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	-0.2	-1	-0.2	-2.3	40.7	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	66.85	-82.3	-112.2	-117	-33	-86.9	-60.5	-32.5	-23.5	5	41.5	-65.2	-61.4	-45.7	11.3	-38	-39.7	0
cash-flows.row.account-receivables	59.5	59.5	-210.1	-66.8	-48.9	-84.7	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-7.3	-7.3	-91.7	-0.8	28.9	-45.1	-45.1	-6.4	-31.9	-21.3	-13.3	25.5	-10.2	-54.5	-5.7	-3.9	-27.9	0
cash-flows.row.account-payables	0	-134.7	188.6	-49.5	-17.8	83.5	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	14.64	0.2	1	0.2	4.8	-40.7	-15.3	-26.1	8.4	26.3	54.8	-90.7	-51.3	8.8	17	-34.1	-11.8	0
cash-flows.row.other-non-cash-items	-71.03	27.4	29.1	-13.2	-54.5	7	-11.3	3.8	1	-1.8	2.7	8.9	6	9.7	-17.7	-7.1	5	-23.3
cash-flows.row.net-cash-provided-by-operating-activities	57.56	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-8.98	-22.5	-41.5	-32.8	-122.6	-93.2	-261.1	-442.8	-267	-51.9	-48.4	-85.8	-113.8	-69.9	-21.9	-23.3	-6.4	-107.6
cash-flows.row.acquisitions-net	-15.45	-15.5	3.9	74.1	215.7	-9.7	261.3	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	8.95	-6	-2.1	-3.9	-176.9	95.1	-45.4	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.sales-maturities-of-investments	7.98	8	-3.9	38.1	144.5	42.9	14.2	0	0	0	0	0	0	0	0	0	0.5	2
cash-flows.row.other-investing-activites	-15.17	1.8	0.8	-32.8	-122.6	-93.2	-261.1	0	496.3	4.5	172.8	0.1	0	0	15.9	46.6	0	0.2
cash-flows.row.net-cash-used-for-investing-activites	-22.66	-34.2	-42.8	42.6	-61.9	-58	-292.1	-442.8	229.3	-47.4	124.5	-85.7	-113.8	-69.9	-6	23.3	-5.9	-105.3
cash-flows.row.debt-repayment	-22.59	-21.5	-14.2	-35.3	-14.5	-17.3	0	0	0	-63	-124	-80	-76	-46	-46	-59	-34	-34
cash-flows.row.common-stock-issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	-0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-1.65	-27.9	-5.1	-61.4	-31.9	-6.6	-6.6	-6.1	-4.6	-4.1	-6.4	-8.6	-7.8	-4.1	-2.5	-2.5	-4	-2.6
cash-flows.row.other-financing-activites	-11.1	-1.3	3.9	3.3	22.9	3.3	13.3	2.3	91.9	495.2	26	156.4	73.1	375.4	47.5	44.3	46	32.7
cash-flows.row.net-cash-used-provided-by-financing-activities	-50.87	-25	-15.5	-93.4	-23.5	-20.6	6.7	-3.8	87.3	428	-104.4	67.8	-10.7	325.3	-1	-17.3	8	-3.9
cash-flows.row.effect-of-forex-changes-on-cash	25.84	0.7	0.7	-0.2	-0.1	-0.1	0	0	0	0.5	0	0.2	0.1	-0.1	-0.1	0	-0.1	-0.3
cash-flows.row.net-change-in-cash	9.86	7.2	14.8	-39.1	-22.6	-30.9	-248.8	-380.2	373.6	445.3	113.8	-28.2	-135.5	257.7	49	9.5	2.7	-3.9
cash-flows.row.cash-at-end-of-period	1376.43	396.3	387.7	372.9	412	434.7	465.5	714.3	1094.5	721	275.6	161.8	190	325.5	67.8	18.7	9.3	-3.9
cash-flows.row.cash-at-beginning-of-period	1366.56	389.1	372.9	412	434.7	465.5	714.3	1094.5	721	275.6	161.8	190	325.5	67.8	18.7	9.3	6.6	0
cash-flows.row.operating-cash-flow	57.56	65.7	72.4	11.9	62.9	47.8	36.7	66.4	56.9	64.1	93.7	-10.5	-11	2.4	56.2	3.5	0.6	105.6
cash-flows.row.capital-expenditure	-8.98	-22.5	-41.5	-32.8	-122.6	-93.2	-261.1	-442.8	-267	-51.9	-48.4	-85.8	-113.8	-69.9	-21.9	-23.3	-6.4	-107.6
cash-flows.row.free-cash-flow	48.58	43.2	30.9	-21	-59.7	-45.3	-224.5	-376.3	-210.1	12.2	45.4	-96.3	-124.8	-67.5	34.3	-19.8	-5.8	-1.9

利润表行

LanZhou Foci Pharmaceutical Co.,Ltd. 的收入与上期相比变化了 0.141%。据报告, 002644.SZ 的毛利润为 361.3。该公司的营业费用为 261.96，与上年相比变化了 102.488%. 折旧和摊销费用为 52.49，与上一会计期间相比变化了 -0.156%. 营业费用报告为 261.96，显示102.488% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长-0.403%. 营业收入为 83.27，与上年相比变化了-0.403%. 净利润的变化率为 -0.382%。去年的净收入为67.19.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008
income-statement-row.row.total-revenue	1130.07	1163.1	1019.2	817.6	668.1	628.8	544.6	501.1	363.3	327.6	399.1	291.5	266.4	271.2	262.4	232.2	219	177.5
income-statement-row.row.cost-of-revenue	765.41	801.8	733	594.5	502.7	461.6	369.7	352.1	255	244.9	310.7	187.7	179.5	178	167.5	144.2	131.8	104.9
income-statement-row.row.gross-profit	364.66	361.3	286.2	223.1	165.4	167.2	174.8	149.1	108.2	82.7	88.4	103.9	86.9	93.2	94.9	88	87.2	72.6
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	31.51	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	17.15	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	154.39	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-2.01	-1.6	-9.7	24.4	13.4	-26.1	0.3	2.2	6.3	7.6	10.9	9.5	6.9	4.8	24	13.5	1.3	-0.4
income-statement-row.row.operating-expenses	262.09	262	129.4	134.6	109.4	98.3	112.8	89.3	74.1	65.3	67.5	71.6	55.5	55.8	57.5	56.1	56.7	38
income-statement-row.row.cost-and-expenses	1027.5	1063.8	862.3	729	612	560	482.6	441.4	329.1	310.2	378.2	259.2	235	233.8	225	200.3	188.5	142.9
income-statement-row.row.interest-income	2.93	5.4	7.5	10.2	12.8	16.3	12.4	30.9	31	23.5	10.2	2.5	2.3	0	0	0.1	0.1	0
income-statement-row.row.interest-expense	0	1.2	0.7	0.9	1.3	1.1	0.6	0	0	1	3.5	5.8	4.9	4.1	3.5	2.5	3.9	3
income-statement-row.row.selling-and-marketing-expenses	154.39	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-2.01	-1.6	-12.4	-1.5	66.1	0.5	24.5	27.6	36.5	31.7	18.5	3.5	3.1	-1.1	18.3	8.7	-4.3	-7.3
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-2.01	-1.6	-9.7	24.4	13.4	-26.1	0.3	2.2	6.3	7.6	10.9	9.5	6.9	4.8	24	13.5	1.3	-0.4
income-statement-row.row.total-operating-expenses	-2.01	-1.6	-12.4	-1.5	66.1	0.5	24.5	27.6	36.5	31.7	18.5	3.5	3.1	-1.1	18.3	8.7	-4.3	-7.3
income-statement-row.row.interest-expense	0	1.2	0.7	0.9	1.3	1.1	0.6	0	0	1	3.5	5.8	4.9	4.1	3.5	2.5	3.9	3
income-statement-row.row.depreciation-and-amortization	40.06	52.5	62.2	32.2	38.7	63	34.2	21	18.5	17.9	14.9	15.2	14.1	6.3	11.3	12.5	13.7	9.7
income-statement-row.row.ebitda-caps	112.68	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	72.62	83.3	139.4	112.4	64.4	78.2	86.1	85.2	64.7	41.5	28.4	26.2	27.6	31.5	31.7	27.1	24.9	27.7
income-statement-row.row.income-before-tax	70.6	81.6	127	110.8	130.5	78.7	86.5	87.4	70.6	49.1	39.3	35.8	34.5	36.3	55.7	40.6	26.2	27.3
income-statement-row.row.income-tax-expense	11.28	13.5	21.1	17.3	22.8	7.8	13.6	13.3	9.7	6.1	4.7	5.2	4.2	4.2	4.5	4.5	4.6	4
income-statement-row.row.net-income	58.12	67.2	108.7	93.3	108	71.1	72.9	74.1	60.9	42.9	34.7	30.6	30.4	32.1	51.2	36.1	21.6	23.3